Clinical Trial Update: A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial comparing linaclotide to placebo in children aged 2 to 5 with functional constipation, focusing on adverse events and changes in symptom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Constipation
• Idiopathic Constipation

Drugs mentioned

• Linzess (linaclotide)

Snippet

Sponsor: AbbVie | Conditions: Functional Constipation (FC), Chronic Idiopathic Constipation (CIC) | Phase 3 | Status: COMPLETED